Last reviewed · How we verify
Fentanyl ITS
At a glance
| Generic name | Fentanyl ITS |
|---|---|
| Also known as | IONSYS |
| Sponsor | Janssen Cilag N.V./S.A. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Cardiac Index and General Anesthesia Without Opioid. (PHASE2, PHASE3)
- Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery (NA)
- Use of Remimazolam and Fentanyl for Procedural Sedation in Patients Undergoing Dental Extraction (PHASE4)
- Effect of Dexmedetomidine Dosage on Postoperative Delirium in Geriatric Orthopedic Surgery (PHASE2)
- Comparison of C-Reactive Protein Levels in Traumatic Brain Injury Patients Undergoing Craniotomy With and Without Dexmedetomidine (PHASE4)
- Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients (PHASE4)
- Characterizing the EEG Signature of Fentanyl and Its Association With Drug Liking
- Investigation of Antibacterial Effect of Levobupivacaine on Staphylococcus Aureus (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fentanyl ITS CI brief — competitive landscape report
- Fentanyl ITS updates RSS · CI watch RSS
- Janssen Cilag N.V./S.A. portfolio CI